Search International and National Patent Collections
|1. (WO2018162727) PHARMACEUTICAL COMBINATIONS COMPRISING AN ANTI-LY75 ANTIBODY|
|Title:||PHARMACEUTICAL COMBINATIONS COMPRISING AN ANTI-LY75 ANTIBODY|
The present disclosure relates generally to the fields of immunology and molecular biology. More specifically, provided herein are pharmaceutical combinations comprising (A) antibodies, or antigen-binding portions thereof, directed against LY75, and (B) a second anti-cancer entity; nucleic acids encoding antibody combinations; methods for preparing antibody combinations; and methods for the treatment of diseases, such as cancers mediated by LY75 expression or activity.